Do anti-malarials in Africa meet quality standards? The market penetration of non quality-assured artemisinin combination therapy in eight African countries

BACKGROUND: Quality of artemisinin-based combination therapy (ACT) is important for ensuring malaria parasite clearance and protecting the efficacy of artemisinin-based therapies. The extent to which non quality-assured ACT (non-QAACT), or those not granted global regulatory approval, are available...

Descripción completa

Detalles Bibliográficos
Autores principales: Newton, Paul N., Hanson, Kara, Goodman, Catherine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5444102/
https://www.ncbi.nlm.nih.gov/pubmed/28539125
http://dx.doi.org/10.1186/s12936-017-1818-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5444102/
https://www.ncbi.nlm.nih.gov/pubmed/28539125
http://dx.doi.org/10.1186/s12936-017-1818-8

Ejemplares similares